Burgos-Vargas, Rubén
Loyola-Sanchez, Adalberto
Ramiro, Sofia
Reding-Bernal, Arturo
Alvarez-Hernandez, Everardo
van der Heijde, Desirée
Vázquez-Mellado, Janitzia
Funding for this research was provided by:
Schering Plough, Mexico
Article History
Received: 25 February 2022
Accepted: 24 July 2022
First Online: 8 August 2022
Declarations
:
: The Research and Ethics Review Board of the Hospital General de Mexico Dr. Eduardo Liceaga approved the conduction of this trial (Hospital General de Mexico Research Division Registry: HGM/DIC/02/404-B/02/036). Patients, parents, or legal guardians and two witnesses were informed about the study and if accepted to participate signed an informed consent form.
: All authors agree to the terms of the BioMed Central Copyright and License Agreement for the publication of this manuscript.
: Dr. Rubén Burgos Vargas received funding from Schering Plough, Mexico, to complete the data collection of this study. None of the other authors received any compensation from this or any other pharmaceutical company for the analysis or interpretation of the results.